Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
European Journal of Nuclear Medicine and Molecular Imaging|February 4, 2015
Radiopharmaceuticals as probes to characterize tumour tissueIsrat S Alam, Mubarik A Arshad, Quang-Dé Nguyen, et al.Seminars in Nuclear Medicine|October 22, 2019
FDG-PET Imaging in Cervical CancerNemi Gandy, Mubarik A Arshad, Won-Ho E Park, et al.The British Journal of Radiology|February 28, 2020
Immunotherapy-related adverse effects on 18F-FDG PET/CT imagingNemi Gandy, Mubarik A Arshad, Kathryn L Wallitt, et al.Nuclear Medicine Communications|January 11, 2020
Interobserver agreement of the visual Herder scale for the assessment of solitary pulmonary nodules on 18F Fluorodeoxyglucose PET/computed tomographyKatherine L Ordidge, Nemi Gandy, Mubarik A Arshad, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 14, 2020
Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomographyMubarik A Arshad, Samuel Gitau, Henry Tam, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 3, 2018
Discovery of pre-therapy 2-deoxy-2-18F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung cancer patientsMubarik A Arshad, Andrew Thornton, Haonan Lu, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 11, 2025
An explainable imaging-clinical biomarker for non-small cell lung cancer prognostication based on normalised hotspot to centroid distance and [18F]FDG PET/CT radiomicsMitchell Chen, Susan J Copley, Yidong Han, et al.Pageof 1